The use of vazobral in chronic cerebral ischemia and headache
|
01.01.2018 |
Parfenov V.
Pozhidaev K.
|
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova |
|
0 |
Ссылка
© 2018, Media Sphera Publishing Group. All rights reserved. The authors describe manifestations of chronic cerebral ischemia (CCI) and present the cases of a combination of primary headache and CCI. Management of patients with CCI and headache and the use of vazobral and its efficacy in treatment of such patients are discussed.
Читать
тезис
|
Mixed dementia: The role of cerebrovascular pathology
|
01.01.2018 |
Tabeeva G.
|
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova |
|
1 |
Ссылка
© 2018, Media Sphera Publishing Group. All rights reserved. Alzheimer’s disease and vascular dementia are two most common causes of dementia in late life. The combination of Alzheimer’s type dementia and vascular dementia is the third most common form of dementia, especially in the elderly. Most clinical forms of dementia are characterized by the presence of «overlap» symptoms of both neurodegenerative and vascular pathology, which makes it expedient to consider mixed dementia as a separate entity characterized by clinical presentations, course and the rate of progression of cognitive decline. Despite the lack of clinical guidelines for management of patients with mixed dementia, it seems appropriate to use strategies that have shown their effectiveness in various types of cognitive impairment.
Читать
тезис
|
Cognitive and motor training for patients with moderate cognitive impairment and mild dementia
|
01.01.2018 |
Naumenko A.
Preobrazhenskaya I.
|
Nevrologiya, Neiropsikhiatriya, Psikhosomatika |
|
1 |
Ссылка
© 2018 Ima-Press Publishing House. All Rights Reserved. Objective: to investigate the effectiveness of cognitive and motor training as an additional method to basic therapy in patients with Alzheimer's disease (AD) and vascular cognitive impairment (VCI). Patients and methods: The investigation enrolled 41 patients (15 women and 26 men; mean age. 73.59±6.3 years), including 32 patients with AD (mean age 74.94±5.15 years) and 9 patients with VCI (mean age, 72.31±4.98 years). Cognitive impairment (CI) corresponded to mild dementia in 15 patients (5 women and 10 men; mean age 74.6±2.8 years) and to moderate dementia in 29 (10 women and 19 men; mean age 72.1±3.2 years). The patients were randomly assigned to individual, group, and mixed (individual and then group) cognitive training groups. Quantitative scales were used to assess changes in CI and emotional and behavioral disorders after 1.5, 3, and 6 months of therapy. Results and discussion: During cognitive and motor training, all the groups showed a significant decrease in the severity of CI (p < 0.05), depression, anxiety, and apathy. The effectiveness of the training was further influenced by the severity of concomitant cardiovascular disease, the degree of apathy, adherence to the training, and the early initiation of basic symptomatic therapy. The greatest positive changes in anxiety and depressive disorders were noted in the patients receiving group cognitive and motor training. Conclusion: The results of the investigation allow group cognitive and motor training to be recommended as a mainstay in the therapy of patients with CI concurrent with emotional disorders.
Читать
тезис
|
Chronic cerebrovascular diseases: Use of vinpocetine in neurological practice (round table proceedings)
|
01.01.2018 |
Parfenov V.
Zhivolupov S.
Zakharov V.
Belova L.
Lagoda O.
Esin R.
Vakhnina N.
Samartsev I.
|
Nevrologiya, Neiropsikhiatriya, Psikhosomatika |
|
0 |
Ссылка
© 2018 Ima-Press Publishing House. All Rights Reserved. The paper presents the proceedings of the Round Table with the participation of leading neurologists, which is devoted to chronic cerebrovascular diseases. It is noted that chronic cerebral ischemia (CCI), or dyscirculatory encephalopathy (DEP), is one of the most common neurological diagnoses in our country. The pathogenesis, clinical presentations, diagnosis and treatment of CCI (DEP) and its matching with vascular cognitive impairment (CI), which is regarded in foreign literature as the main manifestation of chronic cerebrovascular disease (CVD) were considered. The authors analyze clinical trials evaluating the efficacy of vinpocetine (Cavinton) in chronic CVD, dizziness, Cl, as well as the use of new vinpocetine formulations, such as Cavinton Comforte, in various neurological diseases, dysphagia in particular, in poststroke patients.
Читать
тезис
|